Find research datasets worth reusing
Search datasets from major research repositories and use ShareScore to quickly assess how well each record supports discovery, access, and reuse.
989
datasets available to search
ShareScore release 0.9.0
Dataset results
989 results for “myelodysplastic syndrome”
Oral Azacitidine Combined With Venetoclax in Previously Untreated Higher-risk Myelodysplastic Syndromes
ClinicalTrials.gov study NCT05782127. IPD Sharing: NO. Countries: 1. Publications: 0.
Follow up Protocol to the Phase I/II Study of OPN-305 in Second-line or Third-line Lower Lower Risk Myelodysplastic Syndrome
ClinicalTrials.gov study NCT03337451. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Clofarabine in High Risk Myelodysplastic Syndrome (MDS)
ClinicalTrials.gov study NCT01063257. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Phase 1 Study With LYT-200 in Patients With Relapsed/Refractory Acute Myeloid Leukemia (AML), or With Relapsed/Refractory, High-risk Myelodysplastic Syndrome (MDS)
ClinicalTrials.gov study NCT05829226. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Interferon-γ (IFN-γ) With Donor Leukocyte Infusion to Treat Relapsed Acute Myeloid Leukemia and Myelodysplastic Syndromes Post Allogeneic Hematopoietic Stem Cell Transplantation
ClinicalTrials.gov study NCT06529731. IPD Sharing: NO. Countries: 1. Publications: 0.
Vaccine Therapy Plus Immune Adjuvant in Treating Patients With Chronic Myeloid Leukemia, Acute Myeloid Leukemia, or Myelodysplastic Syndrome
ClinicalTrials.gov study NCT00004918. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Vaccine Therapy and GM-CSF in Treating Patients With Low-Risk or Intermediate-Risk Myelodysplastic Syndrome
ClinicalTrials.gov study NCT00513578. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Calcitriol and Dexamethasone in Patients With Myelodysplastic Syndromes
ClinicalTrials.gov study NCT00030069. IPD Sharing: Not stated. Countries: 1. Publications: 0.
SB-715992 in Treating Patients With Acute Leukemia, Chronic Myelogenous Leukemia, or Advanced Myelodysplastic Syndromes
ClinicalTrials.gov study NCT00098826. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Vorinostat and Idarubicin in Treating Patients With Relapsed or Refractory Leukemia or Myelodysplastic Syndromes
ClinicalTrials.gov study NCT00331513. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Outpatient Platelet Transfusions in Myelodysplastic Syndromes and Leukemia: The OPTIMAL Pilot
ClinicalTrials.gov study NCT01615146. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Phase I Study of MGCD0103 Given Twice Weekly in Patients With Leukemia or Myelodysplastic Syndromes
ClinicalTrials.gov study NCT00324194. IPD Sharing: Not stated. Countries: 2. Publications: 0.
A Pilot, Open-Label Study of Luspatercept for Patients With Lower Risk Myelodysplastic Syndromes (MDS)
ClinicalTrials.gov study NCT06113302. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Azacitidine After Chemotherapy and Donor Lymphocyte Infusion in Patients With Relapsed Acute Myeloid Leukemia or Myelodysplastic Syndrome Previously Treated With Donor Stem Cell Transplant
ClinicalTrials.gov study NCT01390311. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Cholecalciferol in Treating Patients With Myelodysplastic Syndrome
ClinicalTrials.gov study NCT00068276. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Ibrutinib and Lenalidomide in Treating Patients With Myelodysplastic Syndrome
ClinicalTrials.gov study NCT03359460. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Combination of Sorafenib and Vorinostat in Poor-risk Acute Myelogenous Leukemia (AML) and High Risk Myelodysplastic Syndrome (MDS)
ClinicalTrials.gov study NCT00875745. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Platelet Response During the Second Cycle of Decitabine Can Predict Response and Survival for Myelodysplastic Syndrome
ClinicalTrials.gov study NCT02045654. IPD Sharing: Not stated. Countries: 1. Publications: 0.
Vorinostat, Cytarabine, and Etoposide in Treating Patients With Relapsed and/or Refractory Acute Leukemia or Myelodysplastic Syndromes or Myeloproliferative Disorders
ClinicalTrials.gov study NCT00357305. IPD Sharing: Not stated. Countries: 1. Publications: 0.
A Study of PLX2853 in Relapsed or Refractory Acute Myeloid Leukemia or High Risk Myelodysplastic Syndrome
ClinicalTrials.gov study NCT03787498. IPD Sharing: Not stated. Countries: 1. Publications: 0.
ScienceDex guides
Understand access before you commit
These curated guides explain access requirements, typical timelines, costs, and reuse considerations for widely used research datasets.
Allen Brain Atlas
Allen Brain Atlas is an Allen Institute collection of brain map atlases, datasets, APIs, and analysis tools covering mouse, human, and non-human primate brain resources.
Annotated Behaviour and Observability Dataset (ABODe)
ABODe is a University of Edinburgh DataShare dataset for behavior classification in group-housed mice using home-cage video, identities, bounding boxes, ground-plate positions, and annotator labels.
DANDI Archive for NWB datasets
DANDI is a BRAIN Initiative archive for publishing and sharing neurophysiology data, including electrophysiology, optophysiology, and behavioral data packaged as NWB and related standards.
International Brain Laboratory public data
The International Brain Laboratory public data releases expose standardized mouse decision-making experiments, including Neuropixels recordings, widefield calcium imaging, behavior, and session metadata accessed through the ONE API.
OpenNeuro
OpenNeuro is a free, open platform for sharing neuroimaging datasets, with public search, dataset pages, and download paths for web, S3, DataLad, and the OpenNeuro CLI.